This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denlinger, L. C.
Right arrow Articles by Bertics, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denlinger, L. C.
Right arrow Articles by Bertics, P. J.

 Previous Article  |  Next Article 

Infect Immun, April 1998, p. 1638-1647, Vol. 66, No. 4
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Nuclear Translocation of NF-kappa B in Lipopolysaccharide-Treated Macrophages Fails To Correspond to Endotoxicity: Evidence Suggesting a Requirement for a Gamma Interferon-Like Signal

Loren C. Denlinger,1,2 Kristen A. Garis,2 Julie A. Sommer,2,3 Arturo G. Guadarrama,1,2 Richard A. Proctor,1,4,* and Paul J. Bertics2,*

Departments of Medical Microbiology and Immunology,1 Biomolecular Chemistry,2 Pharmacology,3 and Medicine,4 University of Wisconsin Medical School, Madison, Wisconsin 53706

Received 15 May 1997/Returned for modification 7 August 1997/Accepted 15 December 1997

Elucidation of a signal transduction pathway essential to lipopolysaccharide (LPS)-induced macrophage activation has the capacity to provide new targets for the treatment of septic shock. In this regard, activation of the transcription factor NF-kappa B is commonly thought to be critical to LPS-stimulated macrophage inflammatory mediator production, although certain immunological, genetic, and molecular evidence suggests that other factors are involved. To address this issue, we hypothesized that the degree of LPS-induced NF-kappa B mobilization should correlate with the murine endotoxicity of the species of LPS used for in vitro study. Therefore, using D-galactosamine-sensitized mice, we assessed the lethal potencies of eight LPS preparations from Escherichia, Salmonella, Klebsiella, Bacteroides, Pseudomonas, Neisseria, and Rhodobacter species as well as that of the endotoxin substructure lipid X. The lethal potencies of these LPS preparations varied by >160-fold. Treatment of RAW 264.7 cells with the same LPS preparations induced levels of tumor necrosis factor alpha (TNF-alpha ) and NO production that correlated with the LPS 50% lethal dose. The combined analysis of the levels of these two mediators produced in response to LPS in RAW cells was found to be a strong predictor of murine endotoxic lethality. Interestingly, while relatively nontoxic in mice, Rhodobacter capsulatus LPS stimulated RAW cell NF-kappa B-like DNA binding protein mobilization and TNF-alpha production to levels comparable to those of more toxic species of LPS but was unable to induce NO generation in RAW cells. These data indicate that neither NF-kappa B activation nor TNF-alpha production alone is a dependable predictor of LPS lethality. Additionally, cotreatment of RAW cells with the potent inflammatory mediator ADP had no effect on the ability of R. capsulatus LPS to stimulate NO production but significantly enhanced induction of NO production by the toxic species of LPS. In contrast, cotreatment of RAW cells or peritoneal macrophages with gamma interferon (IFN-gamma ) normalized the abilities of both toxic and nontoxic LPS preparations to induce NO production, suggesting that selected preparations of LPS may preferentially generate an IFN-gamma -like signal that accounts for enhanced toxicity. In sum, the activation of NF-kappa B does not correspond to LPS lethality, thereby complicating models of macrophage activation that highlight NF-kappa B alone as a signal transduction factor necessary for LPS-mediated toxicity.


* Corresponding author. Mailing address for Paul J. Bertics: Department of Biomolecular Chemistry, University of Wisconsin Medical School, 1300 University Ave., Room 571 Bardeen, Madison, WI 53706. Phone: (608) 262-8667. Fax: (608) 262-5253. E-mail: pbertics{at}macc.wisc.edu. Mailing address for Richard A. Proctor: Department of Medical Microbiology and Immunology, University of Wisconsin Medical School, 1300 University Ave., Room 407 SMI, Madison, WI 53706. Phone: (608) 263-5591. Fax: (608) 262-5253. E-mail: pbertics{at}macc.wisc.edu.




This article has been cited by other articles:

  • Satoh, M., Ando, S., Shinoda, T., Yamazaki, M. (2008). Clearance of bacterial lipopolysaccharides and lipid A by the liver and the role of arginino-succinate synthase. Innate Immunity 14: 51-60 [Abstract]  
  • Totemeyer, S., Sheppard, M., Lloyd, A., Roper, D., Dowson, C., Underhill, D., Murray, P., Maskell, D., Bryant, C. (2006). IFN-{gamma} Enhances Production of Nitric Oxide from Macrophages via a Mechanism That Depends on Nucleotide Oligomerization Domain-2.. J. Immunol. 176: 4804-4810 [Abstract] [Full Text]  
  • Thomas, P. G., Carter, M. R., Da'dara, A. A., DeSimone, T. M., Harn, D. A. (2005). A Helminth Glycan Induces APC Maturation via Alternative NF-{kappa}B Activation Independent of I{kappa}B{alpha} Degradation. J. Immunol. 175: 2082-2090 [Abstract] [Full Text]  
  • Aga, M., Watters, J. J., Pfeiffer, Z. A., Wiepz, G. J., Sommer, J. A., Bertics, P. J. (2004). Evidence for nucleotide receptor modulation of cross talk between MAP kinase and NF-{kappa}B signaling pathways in murine RAW 264.7 macrophages. Am. J. Physiol. Cell Physiol. 286: C923-C930 [Abstract] [Full Text]  
  • Aga, M., Johnson, C. J., Hart, A. P., Guadarrama, A. G., Suresh, M., Svaren, J., Bertics, P. J., Darien, B. J. (2002). Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X7. J. Leukoc. Biol. 72: 222-232 [Abstract] [Full Text]  
  • Watters, J. J., Sommer, J. A., Pfeiffer, Z. A., Prabhu, U., Guerra, A. N., Bertics, P. J. (2002). A Differential Role for the Mitogen-activated Protein Kinases in Lipopolysaccharide Signaling. THE MEK/ERK PATHWAY IS NOT ESSENTIAL FOR NITRIC OXIDE AND INTERLEUKIN 1beta PRODUCTION. J. Biol. Chem. 277: 9077-9087 [Abstract] [Full Text]  
  • Denlinger, L. C., Fisette, P. L., Sommer, J. A., Watters, J. J., Prabhu, U., Dubyak, G. R., Proctor, R. A., Bertics, P. J. (2001). Cutting Edge: The Nucleotide Receptor P2X7 Contains Multiple Protein- and Lipid-Interaction Motifs Including a Potential Binding Site for Bacterial Lipopolysaccharide. J. Immunol. 167: 1871-1876 [Abstract] [Full Text]  
  • Alexander, C., Rietschel, E. Th. (2001). Invited review: Bacterial lipopolysaccharides and innate immunity. Innate Immunity 7: 167-202 [Abstract]  
  • Cramer, L. A., Nelson, S. L., Klemsz, M. J. (2000). Synergistic Induction of the Tap-1 Gene by IFN-{gamma} and Lipopolysaccharide in Macrophages Is Regulated by STAT1. J. Immunol. 165: 3190-3197 [Abstract] [Full Text]  
  • Morikawa, A., Kato, Y., Sugiyama, T., Koide, N., Chakravortty, D., Yoshida, T., Yokochi, T. (1999). Role of Nitric Oxide in Lipopolysaccharide-Induced Hepatic Injury in D-Galactosamine-Sensitized Mice as an Experimental Endotoxic Shock Model. Infect. Immun. 67: 1018-1024 [Abstract] [Full Text]  
  • Hu, Y., Fisette, P. L., Denlinger, L. C., Guadarrama, A. G., Sommer, J. A., Proctor, R. A., Bertics, P. J. (1998). Purinergic Receptor Modulation of Lipopolysaccharide Signaling and Inducible Nitric-oxide Synthase Expression in RAW 264.7 Macrophages. J. Biol. Chem. 273: 27170-27175 [Abstract] [Full Text]